Vergoeding 2018-2022 voor ATC-subgroep A02BA : H2-antagonisten
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| A02BA01 Cimetidine | 82.694 | 419.610 | 196.270 | 238.120 | 337.260 |
| A02BA02 Ranitidine | 2.217.300 | 1.847.300 | 1.055.900 | 878.100 | 781.780 |
| A02BA03 Famotidine (Famosin ®) | 256.730 | 505.590 | 1.775.700 | 3.283.400 | 5.072.000 |
| A02BA04 Nizatidine | 33.653 | 37.331 | 5.018 | 20 | . |
| Totaal | 2.590.377 | 2.809.831 | 3.032.888 | 4.399.640 | 6.191.040 |